Cargando…

Factors associated with strong opioid use for noncancer pain in patients with chronic intestinal failure

BACKGROUND: Chronic analgesic use is described in home parenteral nutrition (HPN)–dependent patients, but there are limited data on factors associated with opioid use for noncancerous pain. METHODS: Patients attending a national UK intestinal failure reference center were divided in two groups accor...

Descripción completa

Detalles Bibliográficos
Autores principales: Deutsch, Liat, Cloutier, Anabelle, Leahy, Gavin, Teubner, Antje, Abraham, Arun, Taylor, Michael, Paine, Peter, Lal, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092843/
https://www.ncbi.nlm.nih.gov/pubmed/36184884
http://dx.doi.org/10.1002/ncp.10916
_version_ 1785023443879591936
author Deutsch, Liat
Cloutier, Anabelle
Leahy, Gavin
Teubner, Antje
Abraham, Arun
Taylor, Michael
Paine, Peter
Lal, Simon
author_facet Deutsch, Liat
Cloutier, Anabelle
Leahy, Gavin
Teubner, Antje
Abraham, Arun
Taylor, Michael
Paine, Peter
Lal, Simon
author_sort Deutsch, Liat
collection PubMed
description BACKGROUND: Chronic analgesic use is described in home parenteral nutrition (HPN)–dependent patients, but there are limited data on factors associated with opioid use for noncancerous pain. METHODS: Patients attending a national UK intestinal failure reference center were divided in two groups according to strong opioid (SO) usage; risk factors for SO usage were analyzed using logistic regression. RESULTS: A total of 168 HPN‐dependent patients were included. During the study period, 73 patients (43.5%) had documented SO usage (SO group), whereas the remainder did not (No‐SO group). The prevalence of Crohn's disease among the No‐SO group was twofold higher than among the SO group (43.2% vs 24.7%; P = 0.013), whereas those with surgical complications were twice as prevalent among the SO group (19.2% vs 8.4%, respectively; P = 0.04). The rate of working‐age unemployment was significantly higher in the SO group (90.6%) than the No‐SO group (55.6%; P = 0.001). Multivariate regression showed unemployment as an independent risk factor for SO usage (OR, 6.005; 95% CI, 1.435–25.134), whereas Crohn's disease (OR, 0.284; 95% CI, 0.09–0.898) and <4 intravenous support (IVS) nights per week (OR, 0.113; 95% CI, 0.012–1.009) were protective factors. The life‐long incidence of catheter‐related bloodstream infection (CRBSI) was comparable between groups (34.2% SO vs 27.4% No‐SO; P = 0.336). CONCLUSION: SO use is frequent among HPN‐dependent patients and associated with high rates of unemployment and ≥4 IVS nights per week, but not with increased rate of CRBSI. The reduced usage among patients with Crohn's disease warrants further evaluation but might be due to the chronicity as compared with other IF etiologies.
format Online
Article
Text
id pubmed-10092843
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100928432023-04-13 Factors associated with strong opioid use for noncancer pain in patients with chronic intestinal failure Deutsch, Liat Cloutier, Anabelle Leahy, Gavin Teubner, Antje Abraham, Arun Taylor, Michael Paine, Peter Lal, Simon Nutr Clin Pract Clinical Research BACKGROUND: Chronic analgesic use is described in home parenteral nutrition (HPN)–dependent patients, but there are limited data on factors associated with opioid use for noncancerous pain. METHODS: Patients attending a national UK intestinal failure reference center were divided in two groups according to strong opioid (SO) usage; risk factors for SO usage were analyzed using logistic regression. RESULTS: A total of 168 HPN‐dependent patients were included. During the study period, 73 patients (43.5%) had documented SO usage (SO group), whereas the remainder did not (No‐SO group). The prevalence of Crohn's disease among the No‐SO group was twofold higher than among the SO group (43.2% vs 24.7%; P = 0.013), whereas those with surgical complications were twice as prevalent among the SO group (19.2% vs 8.4%, respectively; P = 0.04). The rate of working‐age unemployment was significantly higher in the SO group (90.6%) than the No‐SO group (55.6%; P = 0.001). Multivariate regression showed unemployment as an independent risk factor for SO usage (OR, 6.005; 95% CI, 1.435–25.134), whereas Crohn's disease (OR, 0.284; 95% CI, 0.09–0.898) and <4 intravenous support (IVS) nights per week (OR, 0.113; 95% CI, 0.012–1.009) were protective factors. The life‐long incidence of catheter‐related bloodstream infection (CRBSI) was comparable between groups (34.2% SO vs 27.4% No‐SO; P = 0.336). CONCLUSION: SO use is frequent among HPN‐dependent patients and associated with high rates of unemployment and ≥4 IVS nights per week, but not with increased rate of CRBSI. The reduced usage among patients with Crohn's disease warrants further evaluation but might be due to the chronicity as compared with other IF etiologies. John Wiley and Sons Inc. 2022-10-02 2023-02 /pmc/articles/PMC10092843/ /pubmed/36184884 http://dx.doi.org/10.1002/ncp.10916 Text en © 2022 The Authors. Nutrition in Clinical Practice published by Wiley Periodicals LLC on behalf of American Society for Parenteral and Enteral Nutrition. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Clinical Research
Deutsch, Liat
Cloutier, Anabelle
Leahy, Gavin
Teubner, Antje
Abraham, Arun
Taylor, Michael
Paine, Peter
Lal, Simon
Factors associated with strong opioid use for noncancer pain in patients with chronic intestinal failure
title Factors associated with strong opioid use for noncancer pain in patients with chronic intestinal failure
title_full Factors associated with strong opioid use for noncancer pain in patients with chronic intestinal failure
title_fullStr Factors associated with strong opioid use for noncancer pain in patients with chronic intestinal failure
title_full_unstemmed Factors associated with strong opioid use for noncancer pain in patients with chronic intestinal failure
title_short Factors associated with strong opioid use for noncancer pain in patients with chronic intestinal failure
title_sort factors associated with strong opioid use for noncancer pain in patients with chronic intestinal failure
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092843/
https://www.ncbi.nlm.nih.gov/pubmed/36184884
http://dx.doi.org/10.1002/ncp.10916
work_keys_str_mv AT deutschliat factorsassociatedwithstrongopioidusefornoncancerpaininpatientswithchronicintestinalfailure
AT cloutieranabelle factorsassociatedwithstrongopioidusefornoncancerpaininpatientswithchronicintestinalfailure
AT leahygavin factorsassociatedwithstrongopioidusefornoncancerpaininpatientswithchronicintestinalfailure
AT teubnerantje factorsassociatedwithstrongopioidusefornoncancerpaininpatientswithchronicintestinalfailure
AT abrahamarun factorsassociatedwithstrongopioidusefornoncancerpaininpatientswithchronicintestinalfailure
AT taylormichael factorsassociatedwithstrongopioidusefornoncancerpaininpatientswithchronicintestinalfailure
AT painepeter factorsassociatedwithstrongopioidusefornoncancerpaininpatientswithchronicintestinalfailure
AT lalsimon factorsassociatedwithstrongopioidusefornoncancerpaininpatientswithchronicintestinalfailure